Tanżanija - Ingliż - Tanzania Medicinces & Medical Devices Authority

alfa pharmaceuticals limited, tanzania - compound sodium lactate intravenous infusion b.p. (ringer lactate infusion) - intravenous infusion - sodium lactate: 0.32, sodium chloride: 0.6, potassium chloride: 0.04, calcium chloride dihydrate: 0.027

Stati Uniti - Ingliż - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn486 - these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with or without minimal carbohydrate calories, as required by the clinical condition of the patient. solutions containing lactate are not for use in the treatment of lactic acidosis. to open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication prepare additive port. using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. the additive port may be protected by covering with an additive cap. mix container contents thoroughly

Stati Uniti - Ingliż - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with or without minimal carbohydrate calories, as required by the clinical condition of the patient. solutions containing lactate are not for use in the treatment of lactic acidosis. o open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication prepare additive port. using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. the additive port may be protected by covering with an additive cap. mix container contents thoroughly.

Kenja - Ingliż - Pharmacy and Poisons Board

questa care inc. c/o surgilinks ltd 4251 s. higuera st. suite 800 san luis obispo ca - sodium lactate bp sodium chloride bp potassium… - infusion - sodium lactate bp 0.32g sodium chloride bp 0.60g… - intravenous solutions: solutions affecting the

Kenja - Ingliż - Pharmacy and Poisons Board

b. braun pharmaceuticals epz ltd. p.o box 51200- 00100 - sodium lactate sodium chloride injectable grade… - solution for infusion - sodium lactate as lactate 0.32% sodium chloride… - intravenous solutions: solutions producing

Kenja - Ingliż - Pharmacy and Poisons Board

medisel kenya ltd p.o box 540-01000 thika - sodium lactate bp, sodium chloride bp, potassium… - solution for infusion - sodium lactate bp 0.320%w/v, sodium chloride bp… - electrolytes

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - calcium chloride dihydrate 0.27 g;  ;  ;  ;  ; potassium chloride 0.4 g;  ;  ;  ; sodium chloride 6 g;  ;  ;  ;  ;  ; sodium lactate 3.17 g (as 6.34g sodium lactate solution 50%);   - solution for infusion - active: calcium chloride dihydrate 0.27 g         potassium chloride 0.4 g       sodium chloride 6 g           sodium lactate 3.17 g (as 6.34g sodium lactate solution 50%)   excipient: hydrochloric acid sodium hydroxide water for injection - compound sodium lactate (hartmann's) is used for intravenous fluid and electrolyte replacement.

Malta - Ingliż - Medicines Authority

baxter healthcare limited - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - calcium chloride dihydrate 0.27 gram(s)/litre ; potassium chloride 0.4 gram(s)/litre ; sodium chloride 6 gram(s)/litre ; sodium lactate 3.2 gram(s)/litre - blood substitutes and perfusion solutions

Stati Uniti - Ingliż - NLM (National Library of Medicine)

gm scientific, llc - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37) - sodium chloride 600 mg in 100 ml - gms electrolyte solution compound sodium lactate (hartmann’s solution) is indicated as a source of water and electrolytes for all species. it is also used as an alkalinizing agent. gms electrolyte solution compound sodium lactate (hartmann’s solution) is contraindicated in patients with a known hypersensitivity to sodium lactate; congestive heart failure or severe impairment of renal function; clinical states in which the administration of sodium and chloride is detrimental.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

hospira, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, monobasic, monohydrate 276 mg in 1 ml - sodium phosphates injection, usp, 3 mm p/ml is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. the concomitant amount of sodium (na+ 4 meq/ml) must be calculated into total electrolyte dose of such prepared solutions. sodium phosphate is contraindicated in diseases where high phosphorus or low calcium levels may be encountered, and in patients with hypernatremia.